CD133-positive cells have been documented in ovarian cancer tissues in the context of the expression of p-p53(Ser20) and carcinoma stem cell biomarkers and in the fraction of the OvBH-1 cell line [18]. This evidence concerns the gene PROM1 and ovarian carcinoma.